Obstructive sleep apnea (OSA) is associated with an increased risk for cardiovascular events. Whether the mechanism for this association is directly attributable to pro-atherosclerotic effects of OSA or primarily related to obesity is not known. Obesity is common in patients with OSA, and is itself associated with an inflammatory state and insulin resistance. In individuals with both obesity and OSA, the repetitive hypoxia associated with OSA may promote inflammation and insulin resistance. Our primary aim is to test the hypothesis that OSA plays a primary role in the inflammatory state of patients with obesity and moderate-severe OSA, and that therefore the elimination of apnea by continuous positive airway pressure (CPAP) therapy in these patients will more greatly reduce inflammation (measured by C-reactive protein or CRP) than weight loss alone, and that combining these two therapies will have additive effects on reducing inflammation.;
Our second aim i s to test the hypothesis that OSA and obesity independently contribute to the insulin resistant state in these patients, and thus combined weight loss and CPAP therapy will have greater effects on lowering insulin resistance than either therapy alone.
Our third aim i s to test the hypothesis that OSA and obesity contribute independently to vascular endothelial dysfunction, through their effects on inflammation and insulin resistance, and that therefore combining weight loss and CPAP therapy will improve endothelial function more than either therapy alone. To address these aims, we plan to randomize 201 subjects with obesity and moderate-severe OSA, and baseline CRP>1.0 mg/L to 1) weight loss theYapy alone; 2) CPAP therapy alone; or 3) weight loss plus CPAP therapy for 6 months. We will measure CRP, insulin resistance (area under the curve of a glucose tolerance test), and endothelial function (by brachial artery flow studies) at baseline, and weeks 6, 12, and 24. We propose that this study design will provide the best way to separate the independent effects of obesity and OSA on cardiovascular risk.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
1R01HL080076-01A1
Application #
7047533
Study Section
Psychosocial Risk and Disease Prevention Study Section (PRDP)
Program Officer
Twery, Michael
Project Start
2006-05-22
Project End
2011-04-30
Budget Start
2006-05-22
Budget End
2007-04-30
Support Year
1
Fiscal Year
2006
Total Cost
$669,275
Indirect Cost
Name
University of Pennsylvania
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Jain, Snigdha; Gurubhagavatula, Indira; Townsend, Raymond et al. (2017) Effect of CPAP, Weight Loss, or CPAP Plus Weight Loss on Central Hemodynamics and Arterial Stiffness. Hypertension 70:1283-1290
Chirinos, Julio A; Gurubhagavatula, Indira; Teff, Karen et al. (2014) CPAP, weight loss, or both for obstructive sleep apnea. N Engl J Med 370:2265-75
Miranda, J Jaime; Herrera, Victor M; Chirinos, Julio A et al. (2013) Major cardiovascular risk factors in Latin America: a comparison with the United States. The Latin American Consortium of Studies in Obesity (LASO). PLoS One 8:e54056
Chirinos, Julio A (2013) Ventricular-arterial coupling: Invasive and non-invasive assessment. Artery Res 7:
Mohammed, Selma F; Borlaug, Barry A; Roger, Veronique L et al. (2012) Comorbidity and ventricular and vascular structure and function in heart failure with preserved ejection fraction: a community-based study. Circ Heart Fail 5:710-9
Rubin, Mario F; Rosas, Sylvia E; Chirinos, Julio A et al. (2011) Surrogate markers of cardiovascular disease in CKD: what's under the hood? Am J Kidney Dis 57:488-97
Medina-Lezama, Josefina; Pastorius, Catherine A; Zea-Diaz, Humberto et al. (2010) Optimal definitions for abdominal obesity and the metabolic syndrome in Andean Hispanics: the PREVENCION study. Diabetes Care 33:1385-8
Chirinos, Julio A; Rietzschel, Ernst R; De Buyzere, Marc L et al. (2009) Arterial load and ventricular-arterial coupling: physiologic relations with body size and effect of obesity. Hypertension 54:558-66
Chirinos, Julio A; David, Robert; Bralley, J Alexander et al. (2008) Endogenous nitric oxide synthase inhibitors, arterial hemodynamics, and subclinical vascular disease: the PREVENCION Study. Hypertension 52:1051-9
Samaha, Frederick F; Foster, Gary D; Makris, Angela P (2007) Low-carbohydrate diets, obesity, and metabolic risk factors for cardiovascular disease. Curr Atheroscler Rep 9:441-7